wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36356089-67886172-3077-4DA1-A67C-46631FF5F30D
Q36356089-67886172-3077-4DA1-A67C-46631FF5F30D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36356089-67886172-3077-4DA1-A67C-46631FF5F30D
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.
P2860
Q36356089-67886172-3077-4DA1-A67C-46631FF5F30D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36356089-67886172-3077-4DA1-A67C-46631FF5F30D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ee30864083000faac9a5ec3ac3d2fd72683b6e81
P2860
Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure.